Zobrazeno 1 - 10
of 314
pro vyhledávání: '"Ralph W. deVere White"'
Autor:
Ruth L. Vinall, Jane Q. Chen, Neil E. Hubbard, Shola S. Sulaimon, Michael M. Shen, Ralph W. DeVere White, Alexander D. Borowsky
Publikováno v:
Disease Models & Mechanisms, Vol 5, Iss 6, Pp 914-920 (2012)
SUMMARY Tp53 mutations are common in human prostate cancer (CaP), occurring with a frequency of ∼30% and ∼70% in localized and metastatic disease, respectively. In vitro studies have determined several common mutations of Tp53 that have specific
Externí odkaz:
https://doaj.org/article/454ba69abae04d67869f9e4ca7a3fcc8
Autor:
Chong-Xian Pan, Ralph W. deVere White, Chuan-Liang Xu, Jian-Ming Guo, Susan Airhart, Paul T. Henderson, Clifford G. Tepper, Wei Shi, Tzu-Yin Lin, Hongyong Zhang, Weimin Yu, Ai-Hong Ma, Yanjun Zhu, Shu-Xiong Zeng
Ki67 and cleaved caspase 3 expression in BL0440 tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cf8e192808e8ab6f565f3b52ab8e3f0
https://doi.org/10.1158/1078-0432.22468512
https://doi.org/10.1158/1078-0432.22468512
Autor:
Chong-Xian Pan, Ralph W. deVere White, Chuan-Liang Xu, Jian-Ming Guo, Susan Airhart, Paul T. Henderson, Clifford G. Tepper, Wei Shi, Tzu-Yin Lin, Hongyong Zhang, Weimin Yu, Ai-Hong Ma, Yanjun Zhu, Shu-Xiong Zeng
Purpose: Activation of the PI3K pathway occurs in over 40% of bladder urothelial cancers. The aim of this study is to determine the therapeutic potential, the underlying action, and the resistance mechanisms of drugs targeting the PI3K pathway.Experi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::181ca22d3297186ccdcc4679c35f1850
https://doi.org/10.1158/1078-0432.c.6526974
https://doi.org/10.1158/1078-0432.c.6526974
Autor:
Paramita M. Ghosh, Ralph W. deVere White, Ruth L. Vinall, Lingru Xue, Alexandra Zierenberg-Ripoll, Margarita Mikhailova, Elyse van Spyk, Sherra D. Johnson, Anisha Madhav, Maitreyee K. Jathal, Benjamin A. Mooso, Liqun Chen
PDF file - 386K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3427dd74e974fe2a055d1ac17af8c285
https://doi.org/10.1158/1078-0432.22442130.v1
https://doi.org/10.1158/1078-0432.22442130.v1
Autor:
Chong-Xian Pan, Ralph W. deVere White, Chuan-Liang Xu, Jian-Ming Guo, Susan Airhart, Paul T. Henderson, Clifford G. Tepper, Wei Shi, Tzu-Yin Lin, Hongyong Zhang, Weimin Yu, Ai-Hong Ma, Yanjun Zhu, Shu-Xiong Zeng
The mutation status and absolute IC50 of bladder cancer cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d63f130d977259c17939d1acccdcdde4
https://doi.org/10.1158/1078-0432.22468503.v1
https://doi.org/10.1158/1078-0432.22468503.v1
Autor:
Ralph W. deVere White, Hsing-Jien Kung, Christopher P. Evans, Regina Gandour-Edwards, Clifford G. Tepper, Joy C. Yang, Hao G. Nguyen, Meimei Li, Lingru Xue, Ai-Hong Ma, Xu-Bao Shi
miR-124 targets the androgen receptor (AR) transcript, acting as a tumor suppressor to broadly limit the growth of prostate cancer. In this study, we unraveled the mechanisms through which miR-124 acts in this setting. miR-124 inhibited proliferation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62443463d3110ef1fee8211801af6592
https://doi.org/10.1158/0008-5472.c.6507470.v1
https://doi.org/10.1158/0008-5472.c.6507470.v1
Autor:
Ralph W. deVere White, Hsing-Jien Kung, Christopher P. Evans, Regina Gandour-Edwards, Clifford G. Tepper, Joy C. Yang, Hao G. Nguyen, Meimei Li, Lingru Xue, Ai-Hong Ma, Xu-Bao Shi
Legend for Supplementary Figures S1-S5.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5419afebc4bf6d2b1c8172f3628043f7
https://doi.org/10.1158/0008-5472.22408148.v1
https://doi.org/10.1158/0008-5472.22408148.v1
Autor:
Ralph W. deVere White, Hsing-Jien Kung, Christopher P. Evans, Regina Gandour-Edwards, Clifford G. Tepper, Joy C. Yang, Hao G. Nguyen, Meimei Li, Lingru Xue, Ai-Hong Ma, Xu-Bao Shi
Description of additional methods and procedures used in the study. Also includes Supplementary Reference.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e32e7e9352560755ad368c32074cbf5
https://doi.org/10.1158/0008-5472.22408130.v1
https://doi.org/10.1158/0008-5472.22408130.v1
Autor:
Ralph W. deVere White, Hsing-Jien Kung, Christopher P. Evans, Regina Gandour-Edwards, Clifford G. Tepper, Joy C. Yang, Hao G. Nguyen, Meimei Li, Lingru Xue, Ai-Hong Ma, Xu-Bao Shi
Immunostaining of AR-V7 in CWR22 xenografts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e28ff3fe0df3e87b62794065b7f2004
https://doi.org/10.1158/0008-5472.22408133.v1
https://doi.org/10.1158/0008-5472.22408133.v1
Autor:
Paramita M. Ghosh, Kermit L. Carraway, Ralph W. deVere White, Rohit Mehra, Arul M. Chinnaiyan, Javed Siddiqui, Xiao-Hua Lu, XuBao Shi, Regina Gandour-Edwards, Clifford G. Tepper, Ruth Vinall, Roble G. Bedolla, Alfredo Asuncion, Benjamin Mooso, Swagata Bose, Salma Siddiqui, Liqun Chen
Patients with advanced prostate cancer (PCa) are initially susceptible to androgen withdrawal (AW), but ultimately develop resistance to this therapy (castration-resistant PCa, CRPC). Here, we show that AW can promote CRPC development by increasing t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d551144e3ef418633a19a98639367b02
https://doi.org/10.1158/0008-5472.c.6500427
https://doi.org/10.1158/0008-5472.c.6500427